|
US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
|
WO1991005571A1
(en)
*
|
1989-10-10 |
1991-05-02 |
University Of Rochester |
Method for producing bone marrow growth cell factors
|
|
EP0659209A1
(de)
*
|
1991-07-26 |
1995-06-28 |
The University Of Rochester |
Krebstherapie unter verwendung maligner zellen
|
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
|
US7135584B2
(en)
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
EP0781138B1
(de)
*
|
1994-08-29 |
2008-05-21 |
Wake Forest University |
Lipid-analoge zur behandlung von viralen infektionen
|
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
|
IL129096A0
(en)
*
|
1996-09-23 |
2000-02-17 |
Univ Rutgers |
Substituted heterocycles as anti-tumor agents
|
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
|
US6468519B1
(en)
*
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
|
US6486214B1
(en)
*
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
US6140328A
(en)
*
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
CA2282461C
(en)
*
|
1997-12-29 |
2004-04-20 |
John D. Buynak |
2-.beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors
|
|
US6051603A
(en)
*
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
|
AU3239400A
(en)
|
1999-02-22 |
2000-09-04 |
University Of Iowa Research Foundation, The |
Method for inhibiting inflammatory responses
|
|
US6080747A
(en)
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
ATE226208T1
(de)
|
1999-03-09 |
2002-11-15 |
Upjohn Co |
4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
|
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
|
US6258820B1
(en)
*
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
|
US6551998B1
(en)
*
|
1999-06-22 |
2003-04-22 |
University Of Louisville Research Foundation, Inc. |
Antimicrobial agents
|
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
|
WO2001012650A2
(en)
*
|
1999-08-17 |
2001-02-22 |
The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
|
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
|
WO2001053335A2
(en)
*
|
2000-01-20 |
2001-07-26 |
Regents Of The University Of Minnesota |
Peptides with antibacterial activity
|
|
CN1398258A
(zh)
|
2000-03-21 |
2003-02-19 |
法玛西雅厄普约翰美国公司 |
用作抗病毒剂的4－羟基噌啉－3－甲酰胺化合物
|
|
JP2003529601A
(ja)
|
2000-03-21 |
2003-10-07 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−オキソ−１，４−ジヒドロ［１，８］ナフチリジン−３−カルボキサミド
|
|
CA2399991A1
(en)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
US6682892B2
(en)
*
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
AU2001294953A1
(en)
|
2000-09-29 |
2002-04-08 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
US7250172B2
(en)
*
|
2001-01-31 |
2007-07-31 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US6703524B2
(en)
*
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
WO2002096826A2
(en)
*
|
2001-05-29 |
2002-12-05 |
Koninklijke Philips Electronics N.V. |
Metal-ceramic bond
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
WO2003020732A2
(en)
*
|
2001-07-24 |
2003-03-13 |
Alamx, L.L.C. |
7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors.
|
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
|
WO2003014118A1
(en)
|
2001-08-08 |
2003-02-20 |
Pharmacia & Upjohn Company |
THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
|
MXPA04001917A
(es)
*
|
2001-08-31 |
2004-06-15 |
Thomson Licensing Sa |
Contador de secuencia para una corriente audio-visual.
|
|
EP1429776A2
(de)
*
|
2001-09-21 |
2004-06-23 |
PHARMACIA & UPJOHN COMPANY |
Tricyclische indolderivate als 5-ht-liganden
|
|
US6815555B2
(en)
|
2001-09-26 |
2004-11-09 |
Theravance, Inc. |
Substituted phenol compounds useful for anesthesia and sedation
|
|
NZ532062A
(en)
*
|
2001-10-01 |
2006-09-29 |
Univ Virginia |
2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
|
|
WO2003031587A2
(en)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
|
DE60238435D1
(de)
*
|
2001-10-26 |
2011-01-05 |
Scripps Research Inst |
Gezielte thrombose durch gewebefaktor polypeptiden
|
|
JP4628675B2
(ja)
|
2001-11-14 |
2011-02-09 |
ラトガーズ，ザ ステイト ユニバーシティ |
可溶化トポイソメラーゼ毒
|
|
EP1453812B1
(de)
|
2001-11-14 |
2008-08-20 |
Rutgers, The State University |
Cytotoxische mittel
|
|
DE60231555D1
(de)
*
|
2001-11-23 |
2009-04-23 |
Theodore James Anastasiou |
Verbesserte synthese von polyanhydriden
|
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
WO2003063779A2
(en)
*
|
2002-01-25 |
2003-08-07 |
Regents Of The University Of Minnesota |
Selective analgesic agents
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
EP2042181A1
(de)
*
|
2002-02-04 |
2009-04-01 |
ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. |
Verwendung CO- freisetzender Substanzen zur Herstellung eines Medikaments für die Behandlung entzündlicher Erkrankungen
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
JP2005523265A
(ja)
|
2002-02-07 |
2005-08-04 |
ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー |
治療用ポリエステルおよびポリアミド
|
|
WO2003072053A2
(en)
|
2002-02-22 |
2003-09-04 |
The Curators Of The University Of Missouri |
Compounds for treatment of copper overload
|
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
|
JP2005525399A
(ja)
*
|
2002-04-04 |
2005-08-25 |
アラムクス エルエルシー |
セリンおよびメタロ−β−ラクタマーゼの阻害剤
|
|
NZ536796A
(en)
*
|
2002-04-25 |
2007-03-30 |
Scripps Research Inst |
Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant
|
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
US20060093595A1
(en)
*
|
2002-07-05 |
2006-05-04 |
Mahesh Jayachandra |
Methods, compositions and kits for treating damage to excitable tissue
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
EP1539686A1
(de)
*
|
2002-09-11 |
2005-06-15 |
Warner-Lambert Company Llc |
Inhibitoren von faktor xa und anderen an der koagulationskaskade beteiligten serinproteasen
|
|
AU2003295336A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Dennis A. Carson |
Use of etodoclac to treat hyperplasia
|
|
EP2447278B1
(de)
|
2002-10-10 |
2015-04-08 |
Cornell Research Foundation, Inc. |
Neue immunogene Proteine von Leptospira
|
|
EP1552025A4
(de)
*
|
2002-10-18 |
2006-12-13 |
Cylene Pharmaceuticals Inc |
Verfahren zur identifizierung von mittels einer quadruplexstruktur erkannten antiviralen molekülen
|
|
EP1567551A4
(de)
*
|
2002-10-22 |
2008-03-12 |
Univ Texas |
Colostrinin und darin enthaltende peptide als modulatoren von intrazellulären signal-molekülen und apoptose-inhibitoren
|
|
ATE327749T1
(de)
*
|
2002-10-28 |
2006-06-15 |
Paraquest Inc |
Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
|
|
JP2006519763A
(ja)
|
2002-11-08 |
2006-08-31 |
アブリンクス エン．ヴェー． |
治療用ポリペプチドの投与法およびそのためのポリペプチド
|
|
AU2003286002B2
(en)
|
2002-11-08 |
2011-06-16 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060228355A1
(en)
|
2003-11-07 |
2006-10-12 |
Toon Laeremans |
Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
CN100367932C
(zh)
*
|
2002-11-26 |
2008-02-13 |
吉里德科学公司 |
借助梯度的脂质体中药物装填的方法
|
|
EP1581634A4
(de)
*
|
2002-12-10 |
2006-10-25 |
Scripps Research Inst |
Verfahren zur behandlung von drogensucht und zum screening von pharmazeutika dafür
|
|
WO2007062048A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Scripps Research Inst |
Role of proteoglycans in drug dependence
|
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
EP2390270A1
(de)
|
2003-01-10 |
2011-11-30 |
Ablynx N.V. |
Therapeutische Polypeptide, Homologe davon, Fragmente davon und Verwendung bei modulierender plättchenvermittelter Aggregation
|
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
CA2520732C
(en)
|
2003-03-28 |
2012-12-04 |
Sloan-Kettering Institute For Cancer Research |
Migrastatin analogs and uses thereof
|
|
EP1610795A4
(de)
*
|
2003-04-07 |
2007-10-24 |
Cylene Pharmaceuticals Inc |
Heterocyclische substituierte 1,4-dihydro-4-oxo-1,8-naphthpyridin-analoga
|
|
NZ543006A
(en)
*
|
2003-04-07 |
2009-03-31 |
Cylene Pharmaceuticals Inc |
Substituted quinobenzoxazine analogs
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
|
CA2536357A1
(en)
*
|
2003-05-29 |
2004-12-23 |
The Scripps Research Institute |
Targeted delivery to legumain-expressing cells
|
|
SI1653943T1
(sl)
|
2003-06-25 |
2008-08-31 |
Burnham Inst |
Derivati katehola za zdravljenje raka
|
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
JP4769721B2
(ja)
|
2003-08-25 |
2011-09-07 |
トロヴィス ファーマシューティカルズ リミテッド ライアビリティ カンパニー |
置換８−ヘテロアリールキサンチン
|
|
JP2007504144A
(ja)
|
2003-08-26 |
2007-03-01 |
ザ リージェンツ オブ ザ ユニバーシティー オブ コロラド ア ボディー コーポレイト |
セリンプロテアーゼ活性阻害因子、ならびに細菌感染の治療法および組成物におけるその使用方法
|
|
WO2005020928A2
(en)
|
2003-08-29 |
2005-03-10 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
JP2007512234A
(ja)
*
|
2003-10-17 |
2007-05-17 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
治療活性を有する修飾ポリペプチド及びその使用方法
|
|
AU2004296206A1
(en)
*
|
2003-12-04 |
2005-06-23 |
The Scripps Research Institute |
Treatment and preventions of asthma
|
|
DE602004031881D1
(de)
*
|
2003-12-19 |
2011-04-28 |
Univ California |
Verfahren und materialien zur beurteilung von prostatakrebstherapien
|
|
US20090060998A1
(en)
|
2004-01-14 |
2009-03-05 |
Gilead Sciences, Inc. |
Lipid-based dispersions useful for drug delivery
|
|
US7491701B2
(en)
*
|
2004-01-27 |
2009-02-17 |
Boys Town National Research Hospital |
Peptides that bind to HSP90 proteins
|
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
US7718684B2
(en)
*
|
2004-02-24 |
2010-05-18 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
|
EP1737472B1
(de)
|
2004-03-29 |
2014-08-13 |
University Of South Florida |
Wirksame Behandlung von Tumoren und Krebs mit Triciribin
|
|
US8957056B2
(en)
*
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
|
WO2006023272A1
(en)
*
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having a2a agonist activity
|
|
JP5046930B2
(ja)
*
|
2004-08-02 |
2012-10-10 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
Ａ２ａアゴニスト活性を有する修飾５’−リボース基を備えた２−プロピニルアデノシン類似体
|
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
|
EP1793832B1
(de)
*
|
2004-08-25 |
2014-07-23 |
University of Iowa Research |
Geranylgeranylpyrophosphat-synthase-hemmer
|
|
NZ553698A
(en)
*
|
2004-09-13 |
2010-07-30 |
Gilead Sciences Inc |
Delivering iron to an animal
|
|
CA2582766C
(en)
*
|
2004-09-23 |
2014-07-22 |
Sloan-Kettering Institute For Cancer Research |
Isomigrastatin analogs in the treatment of cancer
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
JP5113523B2
(ja)
*
|
2004-10-13 |
2013-01-09 |
アブリンクス ナームローゼ フェンノートシャップ |
アミロイド−βに対するナノ抗体及びアルツハイマー病のような神経変性疾患の治療のためのナノ抗体ＴＭを含むポリペプチド
|
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
CA2594542C
(en)
*
|
2005-01-10 |
2014-03-25 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
|
US7691364B2
(en)
*
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
RS53967B1
(sr)
|
2005-05-13 |
2015-08-31 |
The Regents Of The University Of California |
Diaril hidantoin jedinjenja kao antagonisti receptora androgena za lečenje raka
|
|
EP2949668B1
(de)
|
2005-05-18 |
2019-08-14 |
Ablynx N.V. |
Verbesserte nanokörper-tm gegen tumornekrosefaktor alpha
|
|
BRPI0609797B8
(pt)
|
2005-05-20 |
2021-05-25 |
Ablynx Nv |
nanocorpos melhorados para o tratamento de desordens mediadas por agregação
|
|
US20070025910A1
(en)
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
|
JP4989648B2
(ja)
*
|
2005-08-03 |
2012-08-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
抗癌剤として有用なイルジン類似体
|
|
ES2577514T3
(es)
*
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
|
EP1919867B1
(de)
|
2005-08-29 |
2011-08-17 |
University Of Virginia Patent Foundation |
Lisofyllin-analogika und ihre pharmazeutischen verwendungen
|
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
|
WO2007053794A2
(en)
|
2005-10-21 |
2007-05-10 |
Bezwada Biomedical Llc |
Functionalized phenolic compounds and absorbable therefrom
|
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
|
EP1976861A2
(de)
*
|
2005-11-29 |
2008-10-08 |
The Scripps Research Institute |
Hemmung von tumorzellinvasion, metastasen und angiogenese durch targetting von legumin
|
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
|
US20070161546A1
(en)
*
|
2005-12-15 |
2007-07-12 |
Colm King |
Methods and compositions for treatment of cancer
|
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
US7615649B2
(en)
*
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
|
AU2007217810B2
(en)
*
|
2006-02-21 |
2012-10-11 |
The Ohio State University Research Foundation |
Anticancer agents
|
|
JP2009528291A
(ja)
|
2006-02-27 |
2009-08-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
オキシステロール化合物及びヘッジホッグ経路
|
|
AU2007221020B9
(en)
|
2006-02-28 |
2013-04-04 |
Dart Neuroscience (Cayman) Ltd. |
Therapeutic compounds
|
|
JP2009530392A
(ja)
*
|
2006-03-22 |
2009-08-27 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
タンパク質プレニルトランスフェラーゼの阻害剤
|
|
LT2656841T
(lt)
|
2006-03-27 |
2016-09-26 |
The Regents Of The University Of California |
Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
|
|
MX2008012492A
(es)
|
2006-03-29 |
2008-12-12 |
Univ California |
Compuestos de diariltiohidantoina.
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
|
EP2029597A4
(de)
|
2006-05-31 |
2011-11-23 |
Univ California |
Purinanaloga
|
|
US8318812B2
(en)
*
|
2006-06-02 |
2012-11-27 |
The Ohio State University Research Foundation |
Therapeutic agents for the treatment of lymphoid malignancies
|
|
US20100305136A1
(en)
*
|
2006-06-08 |
2010-12-02 |
Johnny Yasuo Nagasawa |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
|
UA105164C2
(en)
|
2006-06-16 |
2014-04-25 |
Догвуд Фармасьютикалз, Инк |
Substituted 8-[6-amino-3-pyridyl]xanthines
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
EP2102144A4
(de)
|
2006-09-13 |
2011-03-23 |
Univ Rutgers |
Wirkstoffe und ihre oligomere und polymere
|
|
WO2008036244A1
(en)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Use of cyclosporin a to sensitize resistant cancer cells to death receptor ligands
|
|
WO2008108825A2
(en)
*
|
2006-10-10 |
2008-09-12 |
Burnham Institute For Medical Research |
Neuroprotective compositions and methods
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
WO2008065503A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
(r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor
|
|
AU2007336242B2
(en)
|
2006-12-19 |
2012-08-30 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
EP2514767A1
(de)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Gegen Metalloproteinase der ADAM-Familie gerichtete Aminosäuren und Polypeptide damit zur Behandlung von Erkrankungen und Störungen im Zusammenhang mit ADAM
|
|
AU2008213666B2
(en)
|
2007-02-06 |
2013-11-07 |
University Of Louisville Research Foundation, Inc. |
Substituted alkine derivatives as anti-cancer agents
|
|
EP2510946B1
(de)
|
2007-02-07 |
2015-08-05 |
The Regents of The University of California |
Konjugate synthetischer TLR-Agonisten und Verwendung dafür
|
|
US20100143270A1
(en)
*
|
2007-02-21 |
2010-06-10 |
University Of Louisville Research Foubdation |
Therapeutic cotinine compositions
|
|
CA2679301C
(en)
|
2007-02-28 |
2015-08-11 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use in protecting pancreatic .beta.-cells, treating type 1 diabetes, and treating inflammatory and autoimmune diseases
|
|
AU2008331808B2
(en)
|
2007-03-16 |
2014-08-21 |
The Regents Of The University Of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
|
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
|
EP2173352B1
(de)
*
|
2007-07-12 |
2016-09-07 |
University of South Florida |
Inhibitoren von akt/pkb mit antitumoraler wirkung
|
|
WO2009018551A2
(en)
|
2007-08-02 |
2009-02-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
WO2009025797A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
|
EP2182809B1
(de)
|
2007-08-27 |
2018-01-17 |
Dart Neuroscience (Cayman) Ltd |
Therapeutische isoxazolverbindungen
|
|
US8217134B2
(en)
*
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
|
US8048980B2
(en)
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
|
PT3092901T
(pt)
*
|
2007-10-05 |
2020-05-21 |
Senhwa Biosciences Inc |
Análogos de quinolona e respetivos métodos relacionados
|
|
AU2008311827A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
|
US8680291B2
(en)
|
2007-10-26 |
2014-03-25 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
WO2009059030A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
WO2009099650A2
(en)
*
|
2008-02-07 |
2009-08-13 |
Carson Dennis A |
Treatment of bladder diseases with a tlr7 activator
|
|
US8142764B2
(en)
|
2008-02-27 |
2012-03-27 |
University Of Louisville Research Foundation |
Synthetic biofilm-inhibiting peptides
|
|
US20090247466A1
(en)
*
|
2008-03-10 |
2009-10-01 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
|
CA2720763A1
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
|
JP6034023B2
(ja)
|
2008-05-16 |
2016-11-30 |
アブリンクス エン．ヴェー． |
Ｃｘｃｒ４及び他のｇｐｃｒに指向性を有するアミノ酸配列及びそれを含む化合物
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
WO2009153782A1
(en)
|
2008-06-17 |
2009-12-23 |
Ben Gurion University Of The Negev R&D Authority |
Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
|
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
US20110178138A1
(en)
*
|
2008-07-28 |
2011-07-21 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
KR20110068993A
(ko)
*
|
2008-08-05 |
2011-06-22 |
유니버시티 오브 사우스 플로리다 |
인지장애의 치료방법
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
EP2313363A4
(de)
*
|
2008-08-08 |
2014-04-02 |
Univ Florida |
Lipidverbindungen zur unterdrückung der entstehung von tumoren
|
|
US9801865B2
(en)
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
BRPI1008383A2
(pt)
|
2009-02-11 |
2016-02-23 |
Univ California |
composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
|
|
US9562051B2
(en)
|
2009-03-06 |
2017-02-07 |
Rutgers, The State University Of New Jersey |
Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer
|
|
CN102438619A
(zh)
|
2009-03-20 |
2012-05-02 |
衣阿华大学研究基金会 |
作为抗结核剂的异戊二烯化双膦酸盐
|
|
MX2011010681A
(es)
|
2009-04-10 |
2012-01-20 |
Ablynx Nv |
Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r.
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
BRPI1016102A2
(pt)
|
2009-04-15 |
2015-09-01 |
Sanford Burhnham Medical Res Inst |
Inibidores de proteínas anti-apoptótica baseados em naftaleno
|
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
|
WO2010132504A1
(en)
|
2009-05-11 |
2010-11-18 |
University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
|
EP2430016B1
(de)
|
2009-05-13 |
2020-04-01 |
University Of Virginia Patent Foundation |
Hemmer der inv(16)-leukämie
|
|
MX2012000113A
(es)
|
2009-06-30 |
2012-02-29 |
Forest Lab Holdings Ltd |
Compuestos alcoxi-carbonil-amino-alquinil-adenosina y derivados de los mismos como agonistas a2ar.
|
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
|
SG177557A1
(en)
|
2009-07-09 |
2012-02-28 |
Cbt Dev Ltd |
Combined preparation for use as a medicament
|
|
JP2013501003A
(ja)
|
2009-07-31 |
2013-01-10 |
バイオクライスト ファーマシューティカルズ， インコーポレイテッド |
ヤヌスキナーゼ阻害剤としてのピロロ［１，２−ｂ］ピリダジン誘導体
|
|
US9040673B2
(en)
|
2009-08-14 |
2015-05-26 |
University Of Virginia Patent Foundation |
Synthesis and identification of novel RSK-specific inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
US8993535B2
(en)
|
2009-09-04 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
|
KR20120060234A
(ko)
*
|
2009-10-08 |
2012-06-11 |
샌포드-번햄 메디칼 리서치 인스티튜트 |
항암제로서의 아포고시폴론 유도체
|
|
CA2780145A1
(en)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
US8598235B2
(en)
|
2009-12-04 |
2013-12-03 |
Jon E. Grant |
Treating impulse control disorders with catechol-O-methyl-transferase inhibitors
|
|
RU2012130929A
(ru)
|
2009-12-23 |
2014-01-27 |
Байокрист Фармасьютикалз, Инк. |
Гетероциклические соединения в качестве ингибиторов янус-киназы
|
|
EP2516396A1
(de)
|
2009-12-23 |
2012-10-31 |
Wayne State University |
Therapeutische verbindungen
|
|
AU2011218173C1
(en)
|
2010-02-16 |
2015-04-16 |
Aragon Pharmaceuticals, Inc. |
Androgen receptor modulators and uses thereof
|
|
CA2828114A1
(en)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
|
|
WO2011123416A1
(en)
|
2010-03-29 |
2011-10-06 |
Surmodics, Inc. |
Injectable drug delivery formulation
|
|
CN103108861A
(zh)
|
2010-04-02 |
2013-05-15 |
Tsrl公司 |
神经氨酸酶抑制剂
|
|
US20130130965A1
(en)
|
2010-04-08 |
2013-05-23 |
University Of Virginia Patent Foundation |
Method to detect and treat infectious or inflammatory diarrhea based on reg1
|
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
|
EP2576561A1
(de)
|
2010-05-28 |
2013-04-10 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclische verbindungen als januskinasehemmer
|
|
WO2011156626A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2803890A1
(en)
|
2010-06-25 |
2011-12-29 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
US20120083473A1
(en)
|
2010-09-21 |
2012-04-05 |
Johanna Holldack |
Treatment of conditions by toll-like receptor modulators
|
|
WO2012061120A1
(en)
|
2010-10-25 |
2012-05-10 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
WO2012058665A1
(en)
|
2010-10-29 |
2012-05-03 |
University Of Connecticut |
Compositions and methods for modulation and detection of immune and inflammatory responses
|
|
WO2012061260A1
(en)
|
2010-11-01 |
2012-05-10 |
The Ohio State University Research Foundation |
Anti-staphylococcal celecoxib derivatives
|
|
AU2011326034B2
(en)
|
2010-11-12 |
2016-02-04 |
Roche Innovation Center Copenhagen A/S |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
|
WO2012074960A2
(en)
|
2010-11-29 |
2012-06-07 |
The Ohio State University Research Foundation |
Fty720-derived anticancer agents
|
|
US8546397B2
(en)
|
2010-12-20 |
2013-10-01 |
The Ohio State University Research Foundation |
DNA methylation inhibitors
|
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
|
PT2672823T
(pt)
|
2011-02-07 |
2016-11-21 |
Biogen Ma Inc |
Agentes que modulam s1p
|
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
|
WO2012122219A2
(en)
|
2011-03-07 |
2012-09-13 |
University Of Louisville Research Foundation |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
|
MX356426B
(es)
|
2011-04-04 |
2018-05-29 |
Univ Iowa Res Found |
Metodos para mejorar inmunogenicidad de vacuna.
|
|
US20140030341A1
(en)
|
2011-04-06 |
2014-01-30 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
|
US9415112B2
(en)
|
2011-06-20 |
2016-08-16 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial RNA polymerase
|
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
|
EP2729483A1
(de)
|
2011-07-08 |
2014-05-14 |
Regents Of The University Of Minnesota |
Glutathionanaloga und ihre verwendung
|
|
EP2734235B1
(de)
|
2011-07-21 |
2017-03-22 |
Alfama, Inc. |
Kohlenmonoxidfreisetzende rutheniummoleküle und ihre verwendungen
|
|
US9167820B2
(en)
|
2011-07-22 |
2015-10-27 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
DK2739153T3
(en)
|
2011-07-29 |
2018-12-03 |
Medivation Prostate Therapeutics Llc |
TREATMENT OF BREAST CANCER
|
|
WO2013025936A1
(en)
|
2011-08-18 |
2013-02-21 |
Cornell University |
Detection and treatment of metastatic disease
|
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
CA2846860A1
(en)
|
2011-08-30 |
2013-03-07 |
Wayne State University |
Therapeutic compounds and methods
|
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
WO2013036931A1
(en)
|
2011-09-08 |
2013-03-14 |
Western University Of Health Sciences |
Targeted liposomes in cancer therapy
|
|
EP2910549A1
(de)
|
2011-09-15 |
2015-08-26 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalenderivate als rxr-modulatoren zur behandlung von alzheimer-krankheit und krebs
|
|
DK2773325T3
(en)
*
|
2011-11-04 |
2019-01-14 |
Enceladus Pharmaceuticals B V |
LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS BY HUMANS
|
|
WO2013101719A2
(en)
*
|
2011-12-27 |
2013-07-04 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
|
CA2862999A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
WO2013106756A2
(en)
|
2012-01-13 |
2013-07-18 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
WO2013110077A1
(en)
|
2012-01-19 |
2013-07-25 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
|
US9296728B2
(en)
|
2012-01-20 |
2016-03-29 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
US9488664B2
(en)
|
2012-01-25 |
2016-11-08 |
Sbi Pharmaceuticals Co., Ltd. |
Diagnostic agent for tumor
|
|
WO2013113102A1
(en)
|
2012-02-01 |
2013-08-08 |
The Governors Of The University Of Alberta |
USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
EP2822548B1
(de)
|
2012-02-08 |
2019-04-24 |
University of Virginia Patent Foundation |
Langkettige sphingosin-kinasehemmer
|
|
EP2819661B1
(de)
|
2012-03-02 |
2016-11-09 |
The Board of Trustees of the University of Illionis |
Starke antitumorwirkung durch doppelte aktivierung einer verbindung
|
|
AU2013230985B2
(en)
|
2012-03-06 |
2016-05-12 |
The Board Of Trustees Of The University Of Illinois |
Procaspase combination therapy for glioblastoma
|
|
ES2774930T3
(es)
|
2012-03-06 |
2020-07-23 |
Univ Illinois |
Activación de procaspasa 3 mediante terapia de combinación
|
|
AU2013235038A1
(en)
|
2012-03-21 |
2014-10-09 |
Malvika Kaul |
Antimicrobial agents
|
|
WO2013142812A1
(en)
|
2012-03-22 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechain-fluorinated myxopyronin derivatives
|
|
ES2655027T3
(es)
|
2012-03-26 |
2018-02-16 |
University Of Iowa Research Foundation |
Análogos de schweinfurthinas
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
KR20150013232A
(ko)
|
2012-05-07 |
2015-02-04 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
골형성 및 헤지호그 신호전달을 유도하고 지방생성을 억제하는 옥시스테롤 유사체 oxy133
|
|
RU2014148918A
(ru)
|
2012-05-21 |
2016-07-10 |
Кеми Нутра Инк. |
Композиции и способы повышения выносливости и мышечной массы
|
|
US20130338114A1
(en)
|
2012-05-23 |
2013-12-19 |
Chemi Nutra |
Compositions for increasing strength, muscle mass, and lean body mass
|
|
EP2854834A4
(de)
|
2012-05-30 |
2016-05-18 |
Biostrategies LC |
Pflanzenlektine als träger entsprechender wirkstoffe in tierischen und menschlichen zellen
|
|
EP2861558B1
(de)
|
2012-06-15 |
2017-01-18 |
Rutgers, The State University of New Jersey |
Makromoleküle zur behandlung von atherosklerose
|
|
SG11201408397SA
(en)
|
2012-06-18 |
2015-01-29 |
Dart Neuroscience Cayman Ltd |
Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
|
|
ES2689541T3
(es)
|
2012-06-19 |
2018-11-14 |
Rutgers, The State University Of New Jersey |
Agentes antibacterianos: derivados de aril mixopironina
|
|
EP2863910B1
(de)
|
2012-06-20 |
2020-03-11 |
University Of Virginia Patent Foundation |
Zusammensetzungen und verfahren zur regulierung einer glucosehomöostase und einer insulinwirkung
|
|
JP6226974B2
(ja)
|
2012-07-05 |
2017-11-08 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
治療用ビスホスホネート
|
|
CA3078006C
(en)
|
2012-07-10 |
2022-04-26 |
Xpd Holdings, Llc |
Stabilized multi-functional antioxidant compounds and methods of use
|
|
RU2696278C2
(ru)
|
2012-07-18 |
2019-08-01 |
Юниверсити Оф Нотр Дам Дю Лак |
5,5-гетероароматические противоинфекционные соединения
|
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
|
WO2014018874A1
(en)
|
2012-07-26 |
2014-01-30 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
|
EP2877166B1
(de)
|
2012-07-27 |
2018-02-28 |
Biogen MA Inc. |
1-[7-(cis-4-methyl-cyclohexyloxy)-8-trifluoromethyl-naphthalen-2-ylmethyl]-piperidin-4-Carbonsäurederivate als Autotaxin (ATX) Modulatoren zur Behandlung von Entzündungen und Autoimmunerkrankungen
|
|
EP2879683B1
(de)
|
2012-08-01 |
2020-01-22 |
Lewis and Clark Pharmaceuticals, Inc. |
N-alkyl-alkynyladenosin-5-uronamid verbindungen als agonisten des a2a-rezeptors
|
|
KR102157912B1
(ko)
|
2012-08-03 |
2020-09-21 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
효소-활성화 화합물 및 조성물
|
|
EP2879674B1
(de)
|
2012-08-06 |
2017-11-22 |
Biogen MA Inc. |
Verbindungen als s1p-modulierende mittel und/oder atx-modulierende mittel
|
|
WO2014025709A1
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Compounds that are s1p modulating agents and/or atx modulating agents
|
|
WO2014028025A1
(en)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions and methods for treating myotonic dystrophy type 1
|
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
|
WO2014043252A2
(en)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
|
US20150246141A1
(en)
|
2012-09-13 |
2015-09-03 |
Ben-Gurion University Of The Negev Research And Development Authority |
Diagnostic agents with enhanced sensitivity/specificity
|
|
CN105744958B
(zh)
|
2012-09-13 |
2019-11-05 |
长庚医疗财团法人林口长庚纪念医院 |
新颖医药组成物及其用途
|
|
UA117663C2
(uk)
|
2012-09-26 |
2018-09-10 |
Арагон Фармасьютікалз, Інк. |
Антиандроген для лікування неметастатичного кастраційно-резистентного раку передміхурової залози
|
|
EP2906260B1
(de)
|
2012-10-09 |
2019-06-26 |
Case Western Reserve University |
Stabförmige pflanzenvirusnanopartikel als kontrastmittelplattformen
|
|
JP2016501832A
(ja)
|
2012-10-10 |
2016-01-21 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
多機能ラジカル消光剤
|
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
|
WO2014066840A1
(en)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
|
PL2917212T3
(pl)
|
2012-11-08 |
2020-03-31 |
Rutgers, The State University Of New Jersey |
Środki przeciwdrobnoustrojowe
|
|
WO2014074926A1
(en)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
WO2014078778A2
(en)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
ES2749467T3
(es)
|
2012-11-20 |
2020-03-20 |
Biogen Ma Inc |
Agentes moduladores de S1p y/o ATX
|
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
|
CN105026360B
(zh)
|
2013-01-29 |
2017-08-25 |
比奥根Ma公司 |
S1p调节剂
|
|
WO2014124317A1
(en)
|
2013-02-08 |
2014-08-14 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
CN105121068A
(zh)
|
2013-02-15 |
2015-12-02 |
明尼苏达大学董事会 |
颗粒功能化
|
|
JP2016510749A
(ja)
|
2013-03-05 |
2016-04-11 |
ユニヴァーシティー オブ ノートル ダム デュ ラック |
キナゾリノン抗生物質
|
|
JP6282721B2
(ja)
|
2013-03-14 |
2018-02-21 |
ダート・ニューロサイエンス・（ケイマン）・リミテッド |
Ｐｄｅ４阻害剤としての置換ピリジン及びピラジン化合物
|
|
KR20150127172A
(ko)
|
2013-03-14 |
2015-11-16 |
다트 뉴로사이언스 (케이만) 엘티디. |
Mao 억제제로서 치환된 나프티리딘 및 퀴놀린 화합물
|
|
WO2014152725A1
(en)
|
2013-03-15 |
2014-09-25 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
|
US9150520B2
(en)
|
2013-03-15 |
2015-10-06 |
Rexahn Pharmaceuticals, Inc. |
Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one
|
|
EP2970334B1
(de)
|
2013-03-15 |
2018-05-23 |
Biogen MA Inc. |
Makrocyclische verbindungen als irak4-hemmer für die behandlung von entzündlichen erkrankungen
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
US20160024504A1
(en)
|
2013-03-15 |
2016-01-28 |
Constellation Pharmaceuticals, Inc. |
Treating th2-mediated diseases by inhibition of bromodomains
|
|
CN105263500A
(zh)
|
2013-05-02 |
2016-01-20 |
加利福尼亚大学董事会 |
骨选择性成骨性氧固醇-骨靶向剂
|
|
JP6208332B2
(ja)
|
2013-05-06 |
2017-10-04 |
カオシュン・チャン・グン・メモリアル・ホスピタル |
医薬組成物及びその用途
|
|
WO2014194055A1
(en)
|
2013-05-29 |
2014-12-04 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
EP3010507A4
(de)
|
2013-06-22 |
2017-06-07 |
Nitor Therapeutics |
Zusammensetzungen und verfahren zur verstärkung der immunreaktion zur behandlung von infektionskrankheiten und krebs
|
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
|
CA2920100A1
(en)
|
2013-08-01 |
2015-02-05 |
Regents Of The University Of Minnesota |
Drug delivery method
|
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
CN105592850B
(zh)
|
2013-08-06 |
2019-11-15 |
H·李·莫菲特癌症中心研究所公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
WO2015038966A1
(en)
|
2013-09-12 |
2015-03-19 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
|
WO2015057863A1
(en)
|
2013-10-15 |
2015-04-23 |
Regents Of The University Of Minnesota |
Triorthogonal reagents for dual protein conjugation
|
|
WO2015070226A1
(en)
|
2013-11-11 |
2015-05-14 |
Kuality Herbceutics Llc |
Kava derived therapeutic compounds and methods of use thereof
|
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
US10328040B2
(en)
|
2014-01-17 |
2019-06-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic methods
|
|
WO2015120320A1
(en)
|
2014-02-06 |
2015-08-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
|
US20150231077A1
(en)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Amine passivated nanoparticles for cancer treatment and imaging
|
|
CN106232583B
(zh)
|
2014-02-20 |
2020-04-24 |
康奈尔大学 |
用于抑制肌成束蛋白的化合物和方法
|
|
WO2015130805A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dna gridiron compositions and methods
|
|
WO2015130973A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
PT3113772T
(pt)
|
2014-03-07 |
2020-12-15 |
Biocryst Pharm Inc |
Pirazois substituídos por trifluorometilo como inibidores de calicreína plasmática humana
|
|
WO2015153560A1
(en)
|
2014-03-31 |
2015-10-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
CA2946112C
(en)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
|
HRP20212035T1
(hr)
|
2014-04-23 |
2022-04-01 |
Dart Neuroscience Llc |
Pripravci koji sadrže supstituirane [1,2,4]triazolo[1,5-a]pirimidin-7-il spojeve kao inhibitore pde2
|
|
US9708334B2
(en)
|
2014-04-24 |
2017-07-18 |
Dart Neuroscience (Cayman) Ltd. |
Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
US10144732B2
(en)
|
2014-06-06 |
2018-12-04 |
Biogen Ma Inc. |
ATX modulating agents
|
|
US10023521B2
(en)
|
2014-06-13 |
2018-07-17 |
Rutgers, The State University Of New Jersey |
Process and intermediates for preparing poly(anhydride-esters)
|
|
WO2015195563A1
(en)
|
2014-06-16 |
2015-12-23 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
EP3166626B1
(de)
|
2014-07-11 |
2021-04-28 |
Biostrategies LC |
Materialien und verfahren zur behandlung von leiden in zusammenhang mit sulfataseenzymen
|
|
AR101229A1
(es)
|
2014-07-18 |
2016-11-30 |
Biogen Ma Inc |
Agentes inhibidores de irak4
|
|
IL250405B
(en)
|
2014-08-19 |
2022-08-01 |
Miller Marvin J |
Antibacterial sideromycins
|
|
KR20170042778A
(ko)
*
|
2014-08-19 |
2017-04-19 |
고꾸리츠 다이가꾸 호우징 오까야마 다이가꾸 |
면역 세포의 기능 증강 방법 및 면역 세포의 다기능성 평가 방법
|
|
WO2016037171A1
(en)
|
2014-09-05 |
2016-03-10 |
The Cleveland Clinic Foundation |
Flavonoid il-17a inhibitors
|
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
|
PT3191086T
(pt)
|
2014-09-11 |
2021-08-03 |
Univ Iowa Res Found |
Timol e carvacol para utilização em medicina
|
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
|
US10040759B2
(en)
|
2014-11-05 |
2018-08-07 |
Dart Neuroscience (Cayman) Ltd. |
Substituted azetidinyl compounds as GlyT1 inhibitors
|
|
US10239882B2
(en)
|
2014-11-05 |
2019-03-26 |
Dart Neuroscience (Cayman) Ltd. |
Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors
|
|
BR112017009845A2
(pt)
*
|
2014-11-10 |
2018-01-16 |
Del Mar Pharmaceuticals |
dianidrogalactitol juntamente com radiação para tratar carcinoma de célula não pequena dos pulmões e glioblastoma multiforme
|
|
WO2016076929A1
(en)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
|
MX381235B
(es)
|
2014-11-17 |
2025-03-12 |
Cellectar Biosciences Inc |
Análogos de éter fosfolipídico como portadores de fármacos dirigidos a cáncer.
|
|
EP3233910B1
(de)
|
2014-12-19 |
2019-12-11 |
Ablynx N.V. |
Cysteinverknüpfte nanokörperdimere
|
|
EP3250223A1
(de)
|
2015-01-08 |
2017-12-06 |
University of Iowa Research Foundation |
Verfahren zur in-vivo-regenerierung von gelenkknorpel
|
|
US10669543B2
(en)
|
2015-01-16 |
2020-06-02 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
|
US10472340B2
(en)
|
2015-02-17 |
2019-11-12 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted phenothiazines as mitochondrial agents
|
|
AU2016220153B2
(en)
|
2015-02-17 |
2020-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10221143B2
(en)
|
2015-03-03 |
2019-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted anilines for treatment of animal diseases
|
|
US10112917B2
(en)
|
2015-03-03 |
2018-10-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
EP3270967A1
(de)
|
2015-03-06 |
2018-01-24 |
The Cleveland Clinic Foundation |
Änderung des steroidstoffwechsels zur behandlung von steroidabhängiger krankheit
|
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
WO2016164898A1
(en)
|
2015-04-10 |
2016-10-13 |
Rutgers, The State University Of New Jersey |
Kojic acid polymers
|
|
JP6959142B2
(ja)
|
2015-05-06 |
2021-11-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
Ｍｃ１ｒを標的とする放射線療法用作用物質およびコンパニオンイメージング作用物質
|
|
WO2016179587A1
(en)
|
2015-05-07 |
2016-11-10 |
Kuality Herbceutics Llc |
Therapeutic compounds and methods of use thereof
|
|
WO2016187100A1
(en)
|
2015-05-15 |
2016-11-24 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
|
US10188704B2
(en)
|
2015-05-18 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
|
IL256111B2
(en)
|
2015-06-05 |
2023-09-01 |
Univ Illinois |
Treatment of pac combinations
|
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
|
WO2016205397A2
(en)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Target-specific delivery of therapeutic agents
|
|
EP3310355B1
(de)
|
2015-06-16 |
2020-11-11 |
University of Virginia Patent Foundation |
Ptp4a3-hemmer zur behandlung von krebs
|
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
US10478510B2
(en)
|
2015-07-16 |
2019-11-19 |
Case Western Resrve University |
Plant virus particles for delivery of antimitotic agents
|
|
EP3328372A4
(de)
|
2015-07-28 |
2019-03-20 |
University Of Iowa Research Foundation |
Zusammensetzungen und verfahren zur behandlung von krebs
|
|
CN108348779A
(zh)
|
2015-08-02 |
2018-07-31 |
H·李·莫菲特癌症中心研究有限公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
EP3334430B1
(de)
|
2015-08-13 |
2025-02-26 |
San Diego State University Research Foundation |
Atropisomerismus für erhöhte kinasehemmerselektivität
|
|
US9994572B2
(en)
|
2015-09-04 |
2018-06-12 |
Janssen Pharmaceutica Nv |
Therapeutic compounds for pain and synthesis thereof
|
|
SI3355890T1
(sl)
|
2015-10-01 |
2022-04-29 |
Biocryst Pharmaceuticals, Inc. |
Inhibitorji kalikreina človeške plazme
|
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
|
EP3365018A1
(de)
|
2015-10-20 |
2018-08-29 |
The Cleveland Clinic Foundation |
Stimulierung von 11beta-hsd2-expression zur verbesserung der hormontherapie einer steroidabhängigen erkrankung
|
|
WO2017079335A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
|
CN119185322A
(zh)
|
2015-11-20 |
2024-12-27 |
生华生物科技股份有限公司 |
用于治疗癌症的四环喹诺酮类似物组合疗法
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
EP3405465B1
(de)
|
2016-01-20 |
2021-10-13 |
Biogen MA Inc. |
Irak4-hemmer
|
|
TWI854164B
(zh)
|
2016-02-01 |
2024-09-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
US20190046637A1
(en)
|
2016-03-01 |
2019-02-14 |
Biostrategies LC |
Materials and methods for mitigating immune-sensitization
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
|
AU2017238208B2
(en)
|
2016-03-22 |
2022-01-06 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
|
WO2017165836A1
(en)
|
2016-03-24 |
2017-09-28 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
US11091498B2
(en)
|
2016-04-04 |
2021-08-17 |
Rutgers, The State University Of New Jersey |
Topoisomerase poisons
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
MX2018012685A
(es)
|
2016-04-18 |
2019-06-06 |
Michael Morrow Kenneth |
Aislamiento de extractos de plantas.
|
|
RU2018142711A
(ru)
|
2016-05-04 |
2020-06-04 |
Х. Ли Моффитт Кэнсер Сентер Энд Рисёч Инститьют, Инк. |
Средство для целенаправленного воздействия на дельта-опиоидный рецептор для молекулярной визуализации и иммунотерапии рака
|
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
|
US10925869B2
(en)
|
2016-05-26 |
2021-02-23 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Compositions and methods for treating pulmonary vascular disease
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
US11351270B2
(en)
|
2016-06-07 |
2022-06-07 |
University Of Iowa Research Foundation |
Junctophilin-2 fragments and uses therefor
|
|
CN110337293A
(zh)
|
2016-06-20 |
2019-10-15 |
新泽西鲁特格斯州立大学 |
治疗性化合物
|
|
WO2017223565A1
(en)
|
2016-06-24 |
2017-12-28 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
US10918647B2
(en)
|
2016-07-26 |
2021-02-16 |
University Of Southern California |
Selective bromodomain inhibition of fungal Bdf1
|
|
AU2017306558B2
(en)
|
2016-08-03 |
2024-09-19 |
University Of South Florida |
Reelin compositions for treatment of neurological disorders
|
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
|
US11390605B2
(en)
|
2016-08-25 |
2022-07-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
|
|
MX380255B
(es)
|
2016-08-31 |
2025-03-12 |
Dart Neuroscience Llc Star |
Derivados de hidroxinorketamina para el tratamiento de trastornos
|
|
WO2018072602A1
(en)
|
2016-10-17 |
2018-04-26 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
WO2018081513A1
(en)
|
2016-10-31 |
2018-05-03 |
Biocryst Pharmaceuticals, Inc. |
Prodrugs of kallikrein inhibitors
|
|
JP7136795B2
(ja)
|
2016-11-29 |
2022-09-13 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
|
PL3559009T3
(pl)
|
2016-12-22 |
2021-10-25 |
Calithera Biosciences, Inc. |
Kompozycje i sposoby hamowania aktywności arginazy
|
|
AR110590A1
(es)
|
2016-12-27 |
2019-04-10 |
Biogen Ma Inc |
Activador de nrf2
|
|
MX390582B
(es)
|
2016-12-28 |
2025-03-20 |
Dart Neuroscience Llc Star |
Compuestos de pirazolopirimidinona sustituida como inhibidores de fosfodiesterasas 2 (pde2)
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
US20180230105A1
(en)
|
2017-01-13 |
2018-08-16 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
AU2018210393A1
(en)
|
2017-01-20 |
2019-07-25 |
The Regents Of The University Of California |
Inhibitors of the N-terminal domain of the androgen receptor
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
EP3573957B1
(de)
|
2017-01-24 |
2023-04-26 |
Rivara, Mirko |
Zusammensetzungen und verfahren zur blockierung von natriumkanälen
|
|
WO2018140876A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf2 activator
|
|
WO2018140738A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf 2 activator
|
|
ES2926449T3
(es)
|
2017-02-07 |
2022-10-26 |
Biogen Ma Inc |
Agentes inhibidores de ASK1
|
|
WO2018150276A2
(en)
|
2017-02-16 |
2018-08-23 |
Universidad San Sebastian |
The combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological conditions
|
|
US11180459B2
(en)
|
2017-03-10 |
2021-11-23 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
US11993571B2
(en)
|
2017-03-10 |
2024-05-28 |
Rutgers, The State University Of New Jersey |
Indole derivatives as efflux pump inhibitors
|
|
WO2018165614A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
WO2018209355A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
US11896591B2
(en)
|
2017-05-22 |
2024-02-13 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
|
EP3630109A4
(de)
|
2017-05-26 |
2021-03-17 |
Rutgers, the State University of New Jersey |
Inhibitoren für bakterielle abflusspumpen
|
|
TW202417517A
(zh)
|
2017-06-02 |
2024-05-01 |
德商麥克專利有限公司 |
與ｍｍｐ１３結合之免疫球蛋白
|
|
AU2018277310B2
(en)
|
2017-06-02 |
2024-07-11 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
|
HRP20241562T1
(hr)
|
2017-06-02 |
2025-01-31 |
Merck Patent Gmbh |
Adamts vezujući imunoglobulini
|
|
JP7249961B2
(ja)
|
2017-06-02 |
2023-03-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ａｄａｍｔｓ５、ｍｍｐ１３およびアグリカンに結合するポリペプチド
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
US11396523B2
(en)
|
2017-06-22 |
2022-07-26 |
University Of Virginia Patent Foundation |
Proton activated atomic medicine
|
|
US20180371526A1
(en)
|
2017-06-23 |
2018-12-27 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Compositions and methods for detecting viral nucleic acids
|
|
WO2018237134A1
(en)
|
2017-06-23 |
2018-12-27 |
San Diego State University Research Foundation |
Atropisomerism for enhanced kinase inhibitor selectivity
|
|
WO2019005841A1
(en)
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
|
|
CA3069432A1
(en)
|
2017-07-12 |
2019-01-17 |
Dart Neuroscience, Llc |
Substituted benzoxazole and benzofuran compounds as pde7 inhibitors
|
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
|
CN111479805B
(zh)
|
2017-08-29 |
2024-08-13 |
罗格斯新泽西州立大学 |
治疗性吲唑
|
|
CA3074113A1
(en)
|
2017-08-30 |
2019-08-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna nanostructures and methods of making and using rna nanostructures
|
|
AU2018345909A1
(en)
|
2017-10-06 |
2020-04-09 |
Blue Therapeutics, Inc. |
Methods of treating acute or chronic pain
|
|
US10702508B2
(en)
|
2017-10-16 |
2020-07-07 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
|
|
CA3116829A1
(en)
|
2017-10-17 |
2019-04-25 |
The Methodist Hospital System |
Delivery devices
|
|
AU2018368769B2
(en)
|
2017-11-17 |
2024-05-09 |
Cytogel Pharma, Llc |
Polymer agonists of mu opioid receptors
|
|
SG11202004384YA
(en)
|
2017-11-17 |
2020-06-29 |
Univ Illinois |
Cancer therapy by degrading dual mek signaling
|
|
EP3713913A1
(de)
|
2017-11-21 |
2020-09-30 |
Biogen MA Inc. |
Als nrf2-aktivatoren verwendbare tetrahydronaphthalinderivate
|
|
KR102794907B1
(ko)
|
2017-11-27 |
2025-04-14 |
다트 뉴로사이언스, 엘엘씨 |
Pde1 억제제로서의 치환된 푸라노피리미딘 화합물
|
|
EP4431156A3
(de)
|
2017-11-29 |
2024-11-20 |
The Cleveland Clinic Foundation |
Antitumor-tet2-modulierende verbindungen
|
|
AU2018375087B2
(en)
|
2017-11-30 |
2023-10-05 |
Cytogel Pharma, Llc |
Novel analgesic pharmaceutical formulations and uses thereof
|
|
WO2019112885A1
(en)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Treatment of steroid-resistant disease using an anthocyanin and a corticosteroid
|
|
WO2019140140A1
(en)
|
2018-01-10 |
2019-07-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
WO2019160873A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: o-alkyl-deuterated pyronins
|
|
RU2020130050A
(ru)
|
2018-02-15 |
2022-03-15 |
Сэньхва Байосайенсиз, Инк. |
Аналоги хинолонов и их соли, композиции и способ их применения
|
|
WO2019168921A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/parp inhibitor in the treatment of cancer
|
|
JP7386797B2
(ja)
|
2018-02-28 |
2023-11-27 |
ダート・ニューロサイエンス・エルエルシー |
Ｎｏｐ阻害剤としての置換シクロヘキシル化合物
|
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
|
WO2019178267A2
(en)
|
2018-03-13 |
2019-09-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
|
EP3765458B1
(de)
|
2018-03-14 |
2023-01-11 |
Biogen MA Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase-inhibitoren
|
|
TWI873092B
(zh)
|
2018-04-06 |
2025-02-21 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
KR102900692B1
(ko)
|
2018-04-20 |
2025-12-15 |
버지니아 테크 인터렉추얼 프라퍼티스, 인크. |
미토콘드리아 언커플러로서 유용한 이미다조피리딘
|
|
WO2020036654A2
(en)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
|
ES2968222T3
(es)
|
2018-05-14 |
2024-05-08 |
Biogen Ma Inc |
Agentes inhibidores para la tirosina cinasa de Bruton
|
|
BR112020026045A2
(pt)
|
2018-06-19 |
2021-03-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
vírus oncolítico ou terapia do câncer mediada por célula que apresenta antígeno usando interferon tipo i e ligante de cd40
|
|
ES3032286T3
(en)
|
2018-06-27 |
2025-07-16 |
Biogen Ma Inc |
Ask1 inhibiting agents
|
|
US12083138B2
(en)
|
2018-07-09 |
2024-09-10 |
Taiwan Liposome Co., Ltd. |
Methods to reduce complications of intra-articular steroid
|
|
US11730726B2
(en)
|
2018-07-11 |
2023-08-22 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
|
MX2021001567A
(es)
|
2018-08-09 |
2021-04-29 |
Univ Illinois |
Compuestos de imidazotetrazina.
|
|
EP3837265B1
(de)
|
2018-08-14 |
2023-02-22 |
Biogen MA Inc. |
Pyridinmakrocyclenverbindungen als ask1-hemmer
|
|
CN113227070A
(zh)
|
2018-08-14 |
2021-08-06 |
比奥根Ma公司 |
Ask1抑制剂
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
WO2020037116A1
(en)
|
2018-08-17 |
2020-02-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitors
|
|
EP3849994A1
(de)
|
2018-09-13 |
2021-07-21 |
Minneamrita Therapeutics, LLC |
Triptolid und prodrugs davon zur verwendung in verfahren zur behandlung von fibrose, nash und nafld
|
|
AU2019344922B2
(en)
|
2018-09-19 |
2025-02-06 |
Biogen Ma Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
|
JP7476214B2
(ja)
|
2018-10-15 |
2024-04-30 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼ阻害剤の結晶多形
|
|
JP7573878B2
(ja)
|
2018-10-17 |
2024-10-28 |
サンステイト バイオサイエンシーズ， エルエルシー |
治療効果を高めるために単一タンパク質でカプセル化された医薬品
|
|
US12162856B2
(en)
|
2018-10-18 |
2024-12-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
β-catenin and B-cell lymphoma 9 (BCL9) inhibitors
|
|
WO2020106454A2
(en)
|
2018-11-07 |
2020-05-28 |
Regents Of The University Of Minnesota |
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
|
|
EP3876827B1
(de)
|
2018-11-09 |
2023-09-27 |
The University of Rochester |
Verfahren zur bestimmung einer behandlung von krebs auf basis einer antwortvorhersage mittels lichtstreuungstechnologie
|
|
WO2020112889A2
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
AR117252A1
(es)
|
2018-12-05 |
2021-07-21 |
Biogen Ma Inc |
Inhibidores de o-glucoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa de morfolinilo, piperazinilo, oxazepanilo y diazepanilo
|
|
US12269899B2
(en)
|
2018-12-07 |
2025-04-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction
|
|
JP7663237B2
(ja)
|
2019-01-14 |
2025-04-16 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
がん免疫療法のためのｃｄ２００ａｒリガンド
|
|
JP7504898B2
(ja)
|
2019-02-04 |
2024-06-24 |
バイオジェン・エムエイ・インコーポレイテッド |
二環式エーテルｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グルコピラノシダーゼ阻害剤
|
|
US12421224B2
(en)
|
2019-03-08 |
2025-09-23 |
Biogen Ma Inc. |
Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
|
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
|
JP7747523B2
(ja)
|
2019-05-15 |
2025-10-01 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼの阻害剤
|
|
WO2020257658A1
(en)
|
2019-06-20 |
2020-12-24 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
|
PH12022550149A1
(en)
|
2019-07-31 |
2022-11-21 |
Biocryst Pharm Inc |
Dosing regimens for oral complement factor d inhibitors
|
|
PH12022550221A1
(en)
|
2019-08-06 |
2022-12-19 |
Biocryst Pharm Inc |
Process-scale synthesis of a plasma kallikrein inhibitor
|
|
AR120173A1
(es)
|
2019-10-09 |
2022-02-02 |
Biocryst Pharm Inc |
Inhibidores del factor d del complemento para administración oral
|
|
EP4041718A4
(de)
|
2019-10-10 |
2023-12-20 |
Cellectar Biosciences, Inc. |
Phospholipid-flavaglin-konjugate und verfahren zu ihrer verwendung zur gezielten krebstherapie
|
|
EP4048670A1
(de)
|
2019-10-25 |
2022-08-31 |
Accent Therapeutics, Inc. |
Mettl3-modulatoren
|
|
WO2021086966A1
(en)
|
2019-10-29 |
2021-05-06 |
Biogen Ma Inc. |
Spirocyclic o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
|
JP7758664B2
(ja)
|
2019-10-30 |
2025-10-22 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼに対する阻害剤としての縮合型二複素環
|
|
JP7758665B2
(ja)
|
2019-10-30 |
2025-10-22 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｂｔｋ阻害剤としての縮合ピリダジンまたはピリミジン
|
|
JP7646671B2
(ja)
|
2019-12-23 |
2025-03-17 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｂｔｋ阻害剤
|
|
WO2021142230A1
(en)
|
2020-01-10 |
2021-07-15 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
|
US12234578B2
(en)
|
2020-01-29 |
2025-02-25 |
Wisconsin Alumni Research Foundation |
Tannin composite fibers
|
|
AR121715A1
(es)
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
JP2023527281A
(ja)
|
2020-05-18 |
2023-06-28 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
神経炎症の処置のためのｃｋ２阻害剤として使用するための、例えばフラボンなどのクロメン－４－オン誘導体
|
|
JP2023533911A
(ja)
|
2020-07-10 |
2023-08-07 |
チャン グァン メモリアル ホスピタル，リンコウ |
上皮成長因子受容体阻害剤によって誘発される上皮細胞損傷を軽減し及び癌細胞を阻害する組成物の製造のための、β－１アドレナリン受容体アンタゴニストの使用
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
US20240327380A1
(en)
|
2020-08-07 |
2024-10-03 |
Biogen Ma Inc. |
Btk inhibitors
|
|
WO2022051326A1
(en)
|
2020-09-02 |
2022-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lzk‑targeting degraders and methods of use
|
|
CN117098767A
(zh)
|
2020-10-14 |
2023-11-21 |
埃克森特治疗公司 |
Mettl3调节剂
|
|
WO2022150446A1
(en)
|
2021-01-07 |
2022-07-14 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
|
AU2022222781A1
(en)
|
2021-02-22 |
2023-08-24 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
|
US12303564B2
(en)
|
2021-03-19 |
2025-05-20 |
Wisconsin Alumni Research Foundation |
Composite chitosan-tannin-active agent compositions and methods of making and using same
|
|
WO2022212893A1
(en)
|
2021-04-02 |
2022-10-06 |
Biogen Ma Inc. |
Combination treatment methods of multiple sclerosis
|
|
IL308171A
(en)
|
2021-05-04 |
2023-12-01 |
Univ Minnesota |
Contraceptive compounds and methods
|
|
AR125768A1
(es)
|
2021-05-05 |
2023-08-09 |
Biogen Ma Inc |
Compuestos para la degradación dirigida de la tirosina cinasa de bruton
|
|
AU2022297453A1
(en)
|
2021-06-22 |
2024-01-04 |
Crimson Biopharm Inc. |
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors
|
|
US20240293322A1
(en)
|
2021-06-23 |
2024-09-05 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
|
TW202321236A
(zh)
|
2021-07-07 |
2023-06-01 |
美商百健Ｍａ公司 |
用於靶向ｉｒａｋ４蛋白降解之化合物
|
|
EP4366834A1
(de)
|
2021-07-07 |
2024-05-15 |
Biogen MA Inc. |
Verbindungen zum targeting des abbaus von irak4-proteinen
|
|
CA3229861A1
(en)
|
2021-09-01 |
2023-03-09 |
John F. BROGNARD |
Mixed lineage kinase inhibitors and methods of use
|
|
US20250025447A1
(en)
|
2021-11-03 |
2025-01-23 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
EP4429770A1
(de)
|
2021-11-10 |
2024-09-18 |
Biogen MA Inc. |
Btk-inhibitoren
|
|
JP2024544530A
(ja)
|
2021-11-12 |
2024-12-03 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｂｔｋ阻害剤
|
|
EP4433098A1
(de)
|
2021-11-18 |
2024-09-25 |
Cornell University |
Microrna-abhängige mrna-schalter für gewebespezifische mrna-basierte therapien
|
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
|
US20250304586A1
(en)
|
2022-05-10 |
2025-10-02 |
Biogen Ma Inc. |
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
|
JP2025516586A
(ja)
|
2022-05-10 |
2025-05-30 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｔｙｋ２阻害剤
|
|
US20250376477A1
(en)
|
2022-07-01 |
2025-12-11 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024006493A1
(en)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
|
KR20250044681A
(ko)
|
2022-07-08 |
2025-04-01 |
액티오 바이오사이언스, 인크. |
치료용 화합물 및 방법
|
|
WO2024054678A2
(en)
|
2022-09-09 |
2024-03-14 |
Regents Of The University Of Minnesota |
Antibodies against fentanyl and analogs and methods of use thereof
|
|
EP4615842A1
(de)
|
2022-11-09 |
2025-09-17 |
Merck Patent GmbH |
Toll-like-rezeptor-7-agonisten als immunstimulatoren zur auslösung der angeborenen antitumorimmunität
|
|
WO2024112932A1
(en)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
KR20250111173A
(ko)
|
2022-12-07 |
2025-07-22 |
루트거스, 더 스테이트 유니버시티 오브 뉴 저지 |
탄산무수화효소 억제제 및 이의 사용 방법
|
|
WO2024186579A1
(en)
|
2023-03-03 |
2024-09-12 |
Deliver Therapeutics, Inc. |
Protein kinase inhibitors and uses thereof
|
|
WO2024186580A1
(en)
|
2023-03-03 |
2024-09-12 |
Deliver Therapeutics, Inc. |
Protein kinase inhibitors and uses thereof
|
|
WO2024197165A1
(en)
|
2023-03-21 |
2024-09-26 |
University Of Iowa Research Foundation |
Broad spectrum antifungal keto-alkyl-pyridinium compounds
|
|
WO2024206284A2
(en)
|
2023-03-27 |
2024-10-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
WO2024211696A1
(en)
|
2023-04-07 |
2024-10-10 |
Biogen Ma Inc. |
1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases
|
|
WO2024226603A1
(en)
|
2023-04-24 |
2024-10-31 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
TW202517288A
(zh)
|
2023-06-22 |
2025-05-01 |
加拿大商伊吉斯生物製藥公司 |
用於增強傷口癒合及皮膚保健的富集多酚之萵苣組成物
|
|
WO2025019587A1
(en)
|
2023-07-18 |
2025-01-23 |
Regents Of The University Of Minnesota |
Senotherapeutic compounds
|
|
WO2025043115A1
(en)
|
2023-08-23 |
2025-02-27 |
Taxis Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors
|
|
WO2025106633A1
(en)
|
2023-11-15 |
2025-05-22 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
|
WO2025259601A1
(en)
|
2024-06-10 |
2025-12-18 |
Nemagen Discoveries, Inc. |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|